Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
215.27
-8.10 (-3.63%)
At close: Nov 16, 2026, 4:00 PM EST
213.21
-2.06 (-0.96%)
After-hours: Nov 16, 2026, 7:59 PM EST
Moderna Market Cap
Moderna has a market cap or net worth of $87.1 billion as of November 16, 2026. It is the 274th most valuable company in the world and the 153rd biggest in the United States. Its market cap has increased by 799.96% in one year.
Market Cap
87.10B
Enterprise Value
83.36B
1-Year Change
799.96%
Global Rank
Country Rank
#153 United States
Category
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $87.10B, an increase of 1,323.61%. That is a compound annual growth rate of 39.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 87.10B | 655.92% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 137.49B |
| Regeneron Pharmaceuticals | 96.35B |
| argenx SE | 60.96B |
| BeOne Medicines AG | 47.49B |
| Royalty Pharma | 39.52B |
| Revolution Medicines | 36.59B |
| Genmab | 32.67B |
| Roivant Sciences | 28.68B |